Article
18 Sep 2020
District Court Upholds Acclarent Executives' Strict Liability Conviction For Off-Label Promotion
AUTHORS CONTENT
Article
03 Aug 2020
NIH Updates ClinicalTrials.gov Guidance To Address Seife V. HHS
Article
12 Feb 2020
FDA And FTC Announce Collaboration To Promote Biosimilar Competition; FDA Issues Draft Promotional Guidance
Article
12 Aug 2019
FDA CBD Roundup: Agency Continues Existing Enforcement Approach While Reviewing Public Comments And Considering Future Policy Approaches
Article
06 Jun 2019
FDA Issues Final Guidance On "Considerations In Demonstrating Interchangeability With A Reference Product"
Article
05 Dec 2018
Aiming To Foster Innovation, FDA Proposes Regulatory Framework Specific To Prescription Drug Software
Article
18 Jun 2018
FDA Issues Final Guidance Documents Relating To Medical Product Manufacturer Communications
Article
14 Jun 2018
FDA Issues Draft Guidance Regarding Waiver Of Single Shared System REMS Requirement
Article
15 May 2018
FDA Issues Draft Guidance On Devices With Multiple Functions
Article
09 Aug 2017
FDA User Fee Reauthorization Legislation Enacted By Congress
Article
31 Jul 2017
FDA Announces New Digital Health Innovation Programs
Article
26 Jul 2017
FDA Issues Immediately Effective Guidance Allowing Waiver of Informed Consent for Minimal Risk Research
Article
26 Jun 2017
FDA Commissioner Forecasts New, Modernized Digital Health Regulatory Framework
Article
02 Feb 2017
FDA Issues Three Key Documents Relating To Medical Product Manufacturer Communications
Article
19 Jan 2017
FDA Finalizes Guidance On Postmarket Management Of Medical Device Cybersecurity
Article
15 Dec 2016
21st Century Cures Act – Provisions To Promote Drug Development
Article
15 Dec 2016
21st Century Cures Act – Provisions Relating To Digital Health
Article
15 Dec 2016
21st Century Cures Act – Provisions Relating To Reimbursement & Fraud And Abuse
Article
14 Dec 2016
21st Century Cures Act – Provisions Relating To Development Incentives For Certain Classes Of Drugs
Article
15 Nov 2016
FDA Holds Public Hearing On Manufacturer Communication Of Scientific And Medical Information